HOME >> BIOLOGY >> NEWS
High Density Lipoproteins And Coronary Heart Disease

Renowned scientists in the field of lipid research will lead a symposium entitled High Density Lipoproteins and Coronary Heart Disease on Saturday, November 7, 1998 in Dallas, TX. Scientists will review the hypothesis that low levels of high-density lipoprotein (HDL) cholesterol are a risk for coronary heart disease; discuss metabolic disorders that result in this condition; and evaluate treatment options.

The symposium, accredited by Continuing Medical Education at The Johns Hopkins University School of Medicine, will include presentations by:

  • Ernst Schaefer, MD, chief, Lipid Metabolism Laboratory, USDA Human Nutrition Research Center at Tufts University
  • H. Bryan Brewer, MD, chief, Molecular Diseases Branch, National Heart, Lung, and Blood Institute, National Institutes of Health
  • Moti Kashyup, MD, director, Cholesterol Center, Veterans Affairs Medical Center
  • John Guyton, MD, director, Duke Lipid Clinic, Duke University Medical Center
  • Hanna Rubins, MD, associate professor of medicine, University of Minnesota School of Medicine. Dr. Rubins, the Lead Investigator for the High-Density Lipoprotein Intervention Trials (HIT), will be presenting data from HIT on Wednesday, November 11 at 1:00 pm during the American Heart Association Conference.


'"/>

Contact: Karen Peart
k.peart@noonanrusso.com
212-696-4455 ext.343
Noonan/Russo Communications
15-Oct-1998


Page: 1

Related biology news :

1. Study Ensures Effective Ways To Measure Macular Pigment Density
2. Reanalysis Of International Data Finds Sharp Decline In Sperm Density
3. Depression A Risk Factor For Coronary Artery Disease In Men
4. American Heart Association Comment: "Folate And Vitamin B6 From Diet And Supplements In Relation To Risk Of Coronary Heart Disease Among Women"
5. Heart gene yields insights into evolution, disease risk
6. Heartless worms hold clues to cardiac arrhythmias, sudden death
7. Media invited to attend International Society For Heart & Lung Transplantation meeting April 21-24
8. Heart and lung transplantation clinical trial results to be announced at ISHLT meeting
9. Heart may heal with help from oxygen-sensitive genes, new study suggests
10. Heart drug might help fight chronic fungal infections
11. Heart disease among some Japanese may be due to sequencing variation inside a gene

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: High Density Lipoproteins And Coronary Heart Disease

(Date:6/24/2015)... June 24, 2015 Biometry authentication provider ... biometric password solution one face in. ... one face in, entering the expanding biometric ... affordable multifactor-authentication biometric answer to the password problem. ... in partnership with KeyLemon, one face in allows ...
(Date:6/23/2015)... 22, 2015 Research ... of the "Body-Worn Temperature Sensors Market - ... Forecast 2014 - 2020" report to their ... of the global body-worn temperature sensors market. The ... on the basis of types, care setting, patient ...
(Date:6/23/2015)... Fla. , June 23, 2015 /PRNewswire/ ... management and authentication solutions, today announced enhanced functionality ... multi-factor authentication solution.  The enhancements build on ... of the DigitalPersona Altus platform and provide ... compatibility. In today,s environment of ...
Breaking Biology News(10 mins):KeyLemon Announces Partnership With Biometric Password Solution onefacein 2Body-Worn Temperature Sensors Market - Global Industry Analysis 2Crossmatch Releases Enhanced DigitalPersona Altus Advanced Authentication Functionality 2
(Date:6/30/2015)... Americord Registry, one of the fastest growing cord blood banks ... at Kirkland & Ellis LLP, as the newest member of ...   "We are thrilled about Andrew Horne,s ... , CEO of Americord. "He brings a wealth of knowledge ... growth and vision." Andrew Horne is ...
(Date:6/30/2015)... ... ... The maximum number of shares proposed to be purchased in the tender ... restricted stock). On June 29, 2015, the last trading day prior to the commencement ... OTCBB was $2.29 per share. , The tender offer will expire on July 28, ...
(Date:6/30/2015)... , June 30, 2015 /PRNewswire/ - RepliCel ... clinical stage regenerative medicine company focused on the ... first participant in its Phase 1/2 clinical trial ... chronic unilateral Achilles tendinosis, has been enrolled and ... intra-tendon ultrasound-guided injections. RCT-01 is comprised of non-bulbar ...
(Date:6/30/2015)... , ... June 30, 2015 , ... ... digital media company, launched “Cannavoices,” an unprecedented digital video and broadcast initiative. Produced ... also the most dynamic collection of legal medical cannabis stories ever assembled. ...
Breaking Biology Technology:Americord Registry Announces Andrew Horne as Advisory Board Member 2Cryo-Cell Commences Tender Offer to Purchase its Common Stock, Up to 750,000 Shares at $3.25 per Share 2Cryo-Cell Commences Tender Offer to Purchase its Common Stock, Up to 750,000 Shares at $3.25 per Share 3RepliCel Life Sciences Enrolls First Participant in Phase 1/2 Clinical Trial of RCT-01 for Chronic Achilles Tendinosis 2RepliCel Life Sciences Enrolls First Participant in Phase 1/2 Clinical Trial of RCT-01 for Chronic Achilles Tendinosis 3RepliCel Life Sciences Enrolls First Participant in Phase 1/2 Clinical Trial of RCT-01 for Chronic Achilles Tendinosis 4Cannavoices Launches a Legal Medical Cannabis Documentary Initiative 2Cannavoices Launches a Legal Medical Cannabis Documentary Initiative 3
Cached News: